The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. - Wikidata - awgldk - TriplyDB

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

http://www.wikidata.org/entity/Q33792965

about

Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth Nrg-1 belongs to the endothelial differentiation gene family of G protein-coupled sphingosine-1-phosphate receptors Angiotensin II type 2 receptor mediates programmed cell death The AT2 receptor selectively associates with Gialpha2 and Gialpha3 in the rat fetus Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells The angiotensin II type 2 receptor and the kidney.ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development.Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors.Changes in the renin angiotensin system during the development of colorectal cancer liver metastases.Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II.Practical considerations of the pharmacology of angiotensin receptor blockers.Genetic Association Study of Angiotensin II Receptor Types 1 (A168G) and 2 (T1247G and A5235G) Polymorphisms in Breast Carcinoma among Brazilian Women.Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes.Distribution of non-AT1, non-AT2 binding of 125I-sarcosine1, isoleucine8 angiotensin II in neurolysin knockout mouse brains Evolution and pathophysiology of chronic systolic heart failure.Addressing those two that go together: the angiotensin II receptors and their role in blood-flow regulation.Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration.Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells Angiotensin II receptors and drug discovery in cardiovascular disease.The renin-angiotensin-aldosterone system and vascular remodeling.Deciphering the nuclear bile acid receptor FXR paradigm.Obstructive uropathy: an important cause of chronic renal failure in children.Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis Strategies to meet lower blood pressure goals with a new standard in angiotensin II receptor blockade.Angiotensin AT2 receptors: cardiovascular hope or hype?Angiotensin type 2 receptor (AT2R): a challenging twin.Electronic sculpting of ligand-GPCR subtype selectivity: the case of angiotensin II.HIV-associated nephropathy: role of AT2R.Early expression of all the components of the renin-angiotensin-system in human development.Renin angiotensin system in development of mice and men Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall.Angiotensin peptides and lung cancer.The role of perivascular adipose tissue in vascular smooth muscle cell growth.Local fetal lung renin-angiotensin system as a target to treat congenital diaphragmatic hernia AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage.

P2860

Q24563508-6BDFF84C-BF1F-4EF2-BBBD-BF1F64C0128E Q28143305-7E6D6935-347F-4F02-81D0-9B16CFCAEDC7 Q28272739-387188E5-CCEC-4A29-B899-9696FD9E1B36 Q28281919-3E6EB950-DDCB-4BFF-A889-F12905CC9BAF Q28362086-EB6615D4-3902-4F62-A114-461FA7B35C1F Q28505671-578E9412-8550-4076-8D79-C1E7BF002C1C Q29394497-543A9442-EBFA-4685-BC0A-460C58C29BDC Q30413945-CF511A25-AF87-4319-B5DA-878DEE1CF841 Q30434317-DFF3E1AD-71D0-48BA-9925-2171F55BDFAF Q30898615-D90851DE-CB2C-4F11-935E-A2342918C613 Q32032127-44A37B4B-CD81-4DFA-91FD-23F5AF830EA3 Q33551485-019C4CAF-6E05-463A-AFB7-D974AA9EA15F Q33593068-30BCBE28-C6D5-4A5E-ACCD-25B667856DA9 Q33650699-D2A4EC9A-3021-430D-A66C-71F5FFFA0B18 Q34042721-AB118FBB-8323-40BF-B092-BB86062D5C53 Q34075171-EF8956C7-D361-4468-83BD-B7E0BDF3A18C Q34078729-528C6421-BB66-4878-9B4F-10E35A671868 Q34088198-21570AD7-F682-4511-A1E3-7CF1A40D5AB6 Q34238307-E84F7EEF-35C0-4E8B-91A0-DD7EE05E39EB Q34248966-419CD765-ECCE-465D-81CB-68817C9F3021 Q34280097-D026F455-EDB1-462D-8D88-8E38154C8095 Q34496676-6C726276-06BF-43DE-BA17-D2A9CFC2A329 Q34513169-617B6D04-F1E6-4CD1-8C39-A7EF5C437801 Q34626518-9504BDEA-D720-4847-9398-CCF2FE8CD521 Q34708939-E35AA41F-F0BA-441C-B047-9D32D98A4523 Q34731369-759F2303-03FD-4080-974E-FA9ED85A101D Q34970370-D251D205-2754-47D5-8FC0-318AF2EA2E3A Q35045801-5902BCBE-8A27-445B-BC54-15B98056D15E Q35122620-767A4EDF-A02F-4D16-A42C-4FD32DDDCFC5 Q35218190-6107D456-350B-4807-B0AA-8B1620A47754 Q35672941-2179053A-EB4F-4855-B749-359D5109C5C2 Q35782663-60545EB7-CE41-4D33-AA08-3D2A2A88C7D3 Q35782695-F576CDC7-314E-413D-A511-0CB93CD273B9 Q35791973-FB1167AD-25A6-4518-96F7-142D33C758FE Q35855619-00C44BB4-4CD2-4A42-A5BA-2DB93E72FD28 Q35857462-788EEDBE-B9CA-4BE7-968A-F4385AB3BDA7 Q35859753-7A4F52EA-BD28-4503-B971-55C44927C351 Q35872512-C3056B65-602A-43D8-85A3-DD91382F20EF Q35925706-5C4586B4-C8DF-4E52-82E2-604DE3C68117 Q36067015-7DDFBD14-44F9-41E9-9ED9-9071DF409947

P2860

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

http://www.wikidata.org/entity/Q33792965

description

1995 nî lūn-bûn

@nan

1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

The angiotensin II type 2 (AT2 ...... ion study using gene transfer.

@ast

The angiotensin II type 2 (AT2 ...... ion study using gene transfer.

@en

type

label

The angiotensin II type 2 (AT2 ...... ion study using gene transfer.

@ast

The angiotensin II type 2 (AT2 ...... ion study using gene transfer.

@en

prefLabel

The angiotensin II type 2 (AT2 ...... ion study using gene transfer.

@ast

The angiotensin II type 2 (AT2 ...... ion study using gene transfer.

@en

P1433

Q33792965-2FDAD513-7F5F-457F-A42A-3C84D098AF7F

P1476

Q33792965-7D13C1DB-0675-4F32-AB22-20C865492F77

P2093

Q33792965-19B2C8C3-BBFF-468D-B536-7A5CD8376706

Q33792965-221BFA2D-6674-43ED-B8D0-DE6187E5989D

Q33792965-4016FEE5-C102-41CB-8B78-FD5553721BBE

Q33792965-7ED31ECB-C031-4150-8C58-A02B50A3C56B

Q33792965-BBF7EBE7-CD57-41CF-810F-74E80D085AF1

Q33792965-C081991F-2391-4071-B07C-EE36F094F5A0

Q33792965-D8527B39-038D-4DB4-9A81-A48DC15B12AC

Q33792965-EE9EE274-E361-4EC5-B725-D6A23E5000C7

Q33792965-FC177B60-1575-4DC3-868A-E49478F51C78

P2860

Q33792965-0AC10FD6-C00E-45CB-A071-33FEA032EE1F

Q33792965-0FE151E4-F84C-4BA5-9D9F-BBB9A5386596

Q33792965-2366EF2E-D8D4-4BAA-9914-E727B6A52977

Q33792965-3950D0B2-15E2-41F3-9ED9-53F738D4E03E

Q33792965-3D2B81D3-2B93-49D7-8B1E-158D491EA00F

Q33792965-40ECF211-B307-4BA0-88D3-C29C1CDE0EF9

Q33792965-6A93D024-347B-4D1D-8DD0-70A36CB73718

Q33792965-9DFE1A20-CA45-4CC9-BD52-98ABF0E2C3B6

Q33792965-A198A414-D7AE-4BFE-946F-15C20A11805F

Q33792965-AA6EA766-33C7-43A5-B4A3-A07DC3F5AD75

P304

Q33792965-21352029-324D-4BB4-96DF-EEE8A2B313F1

P31

Q33792965-FB52A09A-3719-491E-B4D0-5A54C1FB4C1E

P356

Q33792965-11246638-28C4-4B3C-B7EC-B2CDD55F684F

P407

Q33792965-3E794ED1-6355-4514-8B6C-746F9088A23A

P433

Q33792965-BFA1E1B4-00D5-4D3D-BF3C-ADE200D5FE5F

P478

Q33792965-EB7F04CD-603C-4A4B-97E9-0DA94E8AD3DD

P577

Q33792965-C5AEF7B5-12F7-40EA-81AF-BC1A62374118

P5875

Q33792965-3B9E8695-78A2-4DAC-8A62-955B743642A8

P698

Q33792965-5CB48F31-51EE-4E16-8D10-4DD15595D48C

P932

Q33792965-F9E0DBB4-16FF-4072-A6C8-67D521958C6F

P356

PNAS.92.23.10663

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

The angiotensin II type 2 (AT2 ...... ion study using gene transfer.

@en

P2093

H G Hutchinson

http://www.w3.org/2001/XMLSchema#string

L Zhang

http://www.w3.org/2001/XMLSchema#string

M Fujinaga

http://www.w3.org/2001/XMLSchema#string

M Horiuchi

http://www.w3.org/2001/XMLSchema#string

M Nakajima

http://www.w3.org/2001/XMLSchema#string

R E Pratt

http://www.w3.org/2001/XMLSchema#string

R Morishita

http://www.w3.org/2001/XMLSchema#string

V J Dzau

http://www.w3.org/2001/XMLSchema#string

W Hayashida

http://www.w3.org/2001/XMLSchema#string

P2860

Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury

Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors

Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition

Novel and effective gene transfer technique for study of vascular renin angiotensin system.

Expression of AT2 receptors in the developing rat fetus.

Cloning of cDNA and analysis of the gene for mouse angiotensin II type 2 receptor.

Differential distribution of AT1 and AT2 angiotensin II receptor subtypes in the rat brain during development.

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.

Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.

Insulin and 12-O-tetradecanoylphorbol-13-acetate activation of two immunologically distinct myelin basic protein/microtubule-associated protein 2 (MBP/MAP2) kinases via de novo phosphorylation of threonine and tyrosine residues.

P304

10663-10667

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.92.23.10663

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

1995-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15718962

http://www.w3.org/2001/XMLSchema#string

P698

7479861

http://www.w3.org/2001/XMLSchema#string

P932

40672

http://www.w3.org/2001/XMLSchema#string